Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bionorica Steers U.S. Consumers To Natural Products Through Science

This article was originally published in The Tan Sheet

Executive Summary

Natural product marketer Bionorica looks to science to convince parents about the efficacy of natural remedies for children while they become more aware of possible risks associated with OTC cough and cold formulas

You may also be interested in...



Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA

A potential "reverse switch" of pediatric cough/cold OTC drugs to prescription status would not address concerns about efficacy or misuse of the products, the Consumer Healthcare Products Association says

Ulta’s Upgraded FY2022 Outlook A Good Sign For Holiday Beauty

Ulta has increased its fourth quarter and fiscal 2022 full-year outlook on strong third-quarter comparable store sales growth of 14.5%. Mass beauty is outperforming prestige, but CEO David Kimbell said “it’s hard to know for certain if we are starting to see consumers trade down.”

L’Oréal Partners With Microalgae Biotech For New Cosmetic Actives

French firms L’Oréal and Microphyt partner to drive development of cosmetic solutions based on the latter’s patented, low-carbon process for cultivating microalgae. Already, Microphyt markets three cosmetic ingredients based on microalgae bioactives for enhanced skin vitality and resilience.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS102790

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel